healthŌme

Huntsville, United States Founded: 2021 • Age: 5 yrs
Genetic testing and support services for cancer risks are provided.

About healthŌme

healthŌme is a Healthcare company based in Huntsville (United States) founded in 2021 by David Stertzer. Genetic testing and support services for cancer risks are provided. It operates on a HealthTech model. healthŌme has raised $2 million across 2 funding rounds from investors including American Family Ventures and AllegisCyber Capital. healthŌme has completed 1 acquisition, including Kailos. Its chief executive, as recorded, is Darren Rowe. healthŌme offers products and services including Kadance. Its focus areas include Biotechnology and Genomics. Its legal entity is healthŌme®, Inc. Its competitors include Everlywell, Viome and Color; 3 of its 3 listed competitors have raised funding.

Company details

healthŌme, now known as Kadance, is engaged in providing omics-based products for the critical illness and life insurance industry. Solutions are developed to enhance consumer engagement, extend healthy life, and reduce health inequality. The company leverages genomic science and health navigation to assist individuals in understanding cancer risk, managing treatment responses, and aiding recovery. Their approach addresses barriers in precision cancer care by offering personalized support and innovative insurance programs like Kadance.

  • Headquarters Huntsville, United States
  • Founders David Stertzer
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website healthome.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Healthōme®, Inc.
Key Metrics

Products & Services of healthŌme

healthŌme offers a comprehensive portfolio of products and services, including Kadance.

Kadance
Insurance Program

Kadance is offered as a health insurance enhancement.

Funding Insights of healthŌme

healthŌme has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2M
  • Total Rounds 2
  • Last Round Seed — $2M
  • Investors Count 2

All 2 funding rounds of healthŌme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2024$2MSeed––
–
May 2024Seed–American Family Ventures
Valuation history

2 investors in total: 2 institutional.

Investors in healthŌme

healthŌme has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include American Family Ventures and AllegisCyber Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Corporate-backed venture capital firm focused on fintech, Insurtech, and multiple sectors
amfamventures.comMadison, United States
Cybersecurity investments are made in US seed-to-growth stage firms.
allegiscyber.comPalo Alto, United States
Premium access

Investor details for healthŌme

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of healthŌme

2 people are tracked at healthŌme (2 in leadership).

NameRoleGroup
David Stertzer
Co-FounderLeadership
Darren Rowe
CEOLeadership
Premium access

Complete people profiles for healthŌme

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by healthŌme

healthŌme has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kailos.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of consumer-based genetic testing services
kailosgenetics.comHuntsville, United States2010Jun 2023••••
Premium access

Complete acquisition details for healthŌme

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of healthŌme

4 dated milestones of healthŌme across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded healthŌme is founded.
  2. Acquisition Acquires Kailos.
  3. Funding First funding round.
  4. Funding Latest funding round, Seed, of $2.0M.

Competitors of healthŌme

healthŌme has 3 listed competitors in our database, 3 of them funded. They include Everlywell, Viome and Color.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
everlywell.com2014Austin, United States$330M614
At-home health tests for biomarkers, nutrition, and hormone analysis.
viome.com2016Los Alamos, United States$301.57M136
Machine learning-based bioinformatics solutions for health insights are provided.
color.com2013Burlingame, United States$491.44M687
Cancer care is delivered through a virtual clinic by Color.
Premium access

Detailed competitors of healthŌme

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of healthŌme

The website of healthŌme (healthome.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 52% vs previous month

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as healthŌme (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Healthōme

Premium access

Complete news archive for healthŌme

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about healthŌme

healthŌme was founded in 2021 and raised its 1st funding round 3 years after it was founded.

healthŌme is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.

Darren Rowe is the CEO of healthŌme, as recorded in our data.

healthŌme is a funded company, having raised a total of $2M across 2 funding rounds to date.

healthŌme, now known as Kadance, is engaged in providing omics-based products for the critical illness and life insurance industry. Solutions are developed to enhance consumer engagement, extend healthy life, and reduce health inequality. The company leverages genomic science and health navigation to assist individuals in understanding cancer risk, managing treatment responses, and aiding recovery. Their approach addresses barriers in precision cancer care by offering personalized support and innovative insurance programs like Kadance.

healthŌme's top competitors include Viome, Color and Everlywell.

healthŌme offers Kadance.

healthŌme has made 1 acquisition, including Kailos.

healthŌme has 2 investors. Key investors include American Family Ventures, and AllegisCyber Capital.

healthŌme operates through Healthōme®, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available